TTK Healthcare Ltd. Stock Hits 52-Week Low at Rs.954.75

Stock Price Movement and Market Context

On 29 Jan 2026, TTK Healthcare Ltd. recorded its lowest price in the past year at Rs.954.75. Despite opening with a positive gap of 2.3%, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. The stock’s intraday high reached Rs.984.90, reflecting a 2.3% gain during the session, and it outperformed its sector by 1.39% today. Over the last two days, the stock has posted consecutive gains totalling 0.75%, yet this has not been sufficient to offset the broader decline.

In comparison, the Sensex opened flat but later declined by 227.11 points, or 0.25%, closing at 82,141.85. The benchmark index remains 4.89% below its 52-week high of 86,159.02. While the Sensex trades below its 50-day moving average, the 50DMA itself is positioned above the 200DMA, indicating a mixed technical outlook for the broader market.

Long-Term Performance and Relative Underperformance

TTK Healthcare’s one-year performance stands at -24.16%, significantly underperforming the Sensex’s 7.33% gain over the same period. The stock has also lagged behind the BSE500 index across multiple timeframes, including the last three years, one year, and three months. This persistent underperformance highlights challenges in maintaining investor confidence and market valuation.

The stock’s 52-week high was Rs.1,402, indicating a substantial decline of approximately 31.9% from that peak to the current low. This drop reflects a combination of factors affecting the company’s financial metrics and market perception.

Financial Metrics and Growth Trends

Over the past five years, TTK Healthcare has recorded a modest compound annual growth rate (CAGR) of 6.99% in net sales and 15.42% in operating profit. These figures suggest limited expansion relative to peers in the diversified sector. The company’s return on equity (ROE) stands at 6.5%, which, while positive, is moderate for its industry segment.

Cash and cash equivalents at the half-year mark were reported at Rs.600.89 crore, the lowest level observed in recent periods. Additionally, the debtors turnover ratio for the half-year was 7.40 times, also at a low point, indicating slower collection cycles or increased receivables. Non-operating income accounted for 80.43% of profit before tax (PBT) in the most recent quarter, highlighting a significant reliance on income sources outside core operations.

Valuation and Market Perception

TTK Healthcare’s stock trades at a price-to-book (P/B) ratio of 1.3, which is considered attractive relative to its historical valuations and some peers. However, the price-to-earnings-growth (PEG) ratio is elevated at 8.4, reflecting a disparity between current earnings growth and market price. The company maintains a low average debt-to-equity ratio of zero, indicating a conservative capital structure with minimal leverage.

Despite the company’s size and market presence, domestic mutual funds hold a negligible stake of just 0.01%. Given their capacity for detailed research and due diligence, this limited exposure may reflect cautious sentiment regarding the company’s valuation or business prospects at current price levels.

Sector and Industry Positioning

Operating within the diversified industry and sector, TTK Healthcare faces competition from peers with varying growth trajectories and market capitalisations. The stock’s recent performance and valuation metrics suggest it is trading at a premium compared to the average historical valuations of its sector counterparts, despite subdued growth and profitability indicators.

Mojo Score and Analyst Ratings

TTK Healthcare currently holds a Mojo Score of 37.0, categorised as a Sell grade. This represents a downgrade from its previous Hold rating as of 21 Jul 2025. The market capitalisation grade is rated at 3, reflecting its mid-cap status within the diversified sector. These assessments incorporate a range of financial and market performance indicators, underscoring the cautious stance adopted by rating methodologies.

Summary of Key Performance Indicators

To summarise, TTK Healthcare’s stock has experienced a notable decline to Rs.954.75, its lowest level in 52 weeks. The stock’s underperformance relative to the Sensex and BSE500 indices, combined with subdued growth rates and financial ratios, has contributed to this trend. While the company maintains a conservative debt profile and an attractive price-to-book valuation, other metrics such as the PEG ratio and reliance on non-operating income highlight areas of concern.

Market participants will note the stock’s recent short-term gains and outperformance of its sector today, but the broader context remains one of subdued momentum and valuation pressures.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →